暂时过来 发表于 2025-3-27 00:11:18
http://reply.papertrans.cn/59/5891/589072/589072_31.pngCloudburst 发表于 2025-3-27 04:19:19
Immunotherapy and Radiotherapy: New Strategies, its application has the potential to liberate tumor antigen in the context of pro-inflammatory cell death. This chapter describes interactions between radiotherapy and the immune system, with a particular focus on an emerging mechanistic understanding of how radiation can materially contribute to an anti-tumor immune response.傻瓜 发表于 2025-3-27 05:35:22
2199-2584 so include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement..978-3-030-74030-6978-3-030-74028-3Series ISSN 2199-2584 Series E-ISSN 2199-2592averse 发表于 2025-3-27 10:03:04
http://reply.papertrans.cn/59/5891/589072/589072_34.pngCreatinine-Test 发表于 2025-3-27 13:36:56
Immune Therapy: What Can We Learn From Acquired Resistance?, defects in IFN- γ signaling, upregulation of alternative immune checkpoint pathways, and various tumor genomic or epigenetic changes have been implicated. In this review, we propose clinical criteria, highlight emerging management strategies, and discuss mechanistic insights into acquired resistance to PD-1 axis inhibitors in NSCLC.使显得不重要 发表于 2025-3-27 18:03:11
http://reply.papertrans.cn/59/5891/589072/589072_36.pngHamper 发表于 2025-3-27 23:25:24
http://reply.papertrans.cn/59/5891/589072/589072_37.png其他 发表于 2025-3-28 05:53:48
Small Cell Lung Cancer: Biology Advances,al regulators. These analyses are leading to a better understanding of SCLC biology and may help identify distinct therapeutic vulnerabilities among subsets of this disease. Ideally, these investigations will lead to more personalized therapeutic approaches and better outcomes for patients diagnosed with this aggressive cancer.inchoate 发表于 2025-3-28 07:42:43
2199-2584 gy to inform clinical management in patients treated with im.Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, un用不完 发表于 2025-3-28 13:55:06
aser systems are and follow-up data. A detailed description of available to the clinician and the researcher, laser recanalization techniques is presented for which often makes the choice of a laser system the various systems in the clinical setting.978-1-4612-8801-5978-1-4613-1489-9Series ISSN 0166-9842